Pharmaceutical & Biotechnology Environment Monitoring Market Size & Share, by Type (Monitoring Equipment, Media, Software, Microbiology Services), End-user (Pharmaceutical, Biotechnology, Academic & Research Institutes) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2024-2036

  • Report ID: 3931
  • Published Date: Jul 26, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2024 - 2036

Pharmaceutical & Biotechnology Environment Monitoring Market size was valued at USD 1.04 Billion in 2023 and is set to reach USD 2.36 Billion by the end of 2036, registering around 6.5% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of pharmaceutical & biotechnology environment monitoring is assessed at USD 1.1 Billion. This market is anticipated to grow in the near future due to increased safety-related awareness among researchers in the pharmaceutical sector. Global biotechnology accounted for USD 266 billion in drug revenues in 2019, a figure that has been steadily growing for the past several years. It is projected to reach USD 505 billion by 2026, while the conventional drug market is expected to be worth USD 681 billion that same year.

With the adoption of modern technologies that have shown to be more efficient and economical, the pharmaceutical sector has undergone a significant transition. The expansion of this market has been positively affected by an increase in the flow of investment. Each year, the pharmaceutical sector as a whole invests more than USD  80 billion in research and development in the United States.


Pharmaceutical & Biotechnology Environment Monitoring Market Overview
Get more information on this report: Request Free Sample PDF

Pharmaceutical & Biotechnology Environment Monitoring Market: Growth Drivers and Challenges

Growth Drivers

  • Increasing Demand for Artificial Intelligence and Information Technology- The usage of cloud technology including private and public cloud, increased emphasis on the value of research and development, precision medicine, and other digital processes are about to undergo some dramatic developments in the pharmaceutical and biotechnology environment monitoring industry. The pharmaceutical and biotechnology industries may now work together with several different stakeholders for the same market thanks to cloud technology. According to a survey, 98% of all respondent businesses have a multi-cloud strategy in place or in development. Additionally, the cloud will host 82% of the workload.
  • Rising Need for Cold Storage Solutions- The pharmaceutical and biotechnology industries have benefited from R&D for the treatment of COVID-19 since the primary vaccine developed required a safe cold storage solution service. The necessity for cold chain services to assist in the monitoring and transportation of the vaccinations and other pertinent goods to their destination was great.
  • Increasing Requirement for Storage and Delivery Services- The delivery of goods by sea and air is another factor boosting the development of this industry. Such a need can be seen as a result of lower long-term average ocean and air freight costs, which may be coupled with an increase in demand from biologics, temperature-sensitive pharmaceuticals, and other protein segments. 

Challenges-

  • Concerns About Health and Safety Might Change Market Dynamics- In the pharmaceutical and biotechnology industries, health and safety are crucial for long-term viability and increased output. Biological and chemical risks, which have been shown to represent a major threat to those working in these settings, are mostly exposed in this business.  Along with this, a lack of safety regulations and non-compliance may affect employee productivity and, in the long run, have an adverse effect on the expansion of the organization.
  • Researchers are Few in Undeveloped Countries
  • Rising Costs Across the Business

Pharmaceutical & Biotechnology Environment Monitoring Market: Key Insights

Base Year

2023

Forecast Year

2024-2036

CAGR

6.5%

Base Year Market Size (2023)

 USD 1.04 Billion

Forecast Year Market Size (2036)

 USD 2.36 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Pharmaceutical & Biotechnology Environment Monitoring Segmentation

Type (Monitoring Equipment, Media, Software, Microbiology Services)

The monitoring equipment segment in the pharmaceutical & biotechnology environment monitoring market is anticipated to have the largest revenue with a 30% share in the upcoming years. Environmental monitoring parameters for the pharmaceutical and biotechnology industries are tracked using monitoring equipment. A few of them are airflow analysis, particle counters for air emissions, temperature, humidity, and pressure monitors. Microbiology tools like Bioburden Testing (Bacillus count), Endotoxin Testing (LAL assay), and Mycoplasma Detection Test Instruments are within the category of monitoring equipment. Instruments for counting particles, such as photometer-based contamination detectors and laser scattering detectors, etc.

End-User (Pharmaceutical Industry, Biotechnology Industry, Academic & Research Institutes)

The academic & research institutes are set to have a 25% of the global pharmaceutical & biotechnology environment monitoring market share. Multiple layers of pharmaceutical and biotechnological research necessitate the monitoring of diverse environmental variables. The pH, which has a direct impact on the majority of biochemical activities taking place in laboratories or industrial facilities, is one such crucial parameter that has to be monitored. Additionally, as researchers become more aware of safety issues, stricter regulatory guidelines are applied to them globally. As a result, many universities around the world are forced to make significant investments in pharmaceutical and biotechnological equipment and services.

Our in-depth analysis of the global market includes the following segments:

          Type

  • Monitoring Equipment
  • Media
  • Software
  • Microbiology Services

          End - User

  • Pharmaceutical Industry
  • Biotechnology Industry
  • Academic & Research Institutes

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Pharmaceutical & Biotechnology Environment Monitoring Industry - Regional Synopsis

APAC Market Forecast

Asia Pacific region is expected to have a 35% of the global pharmaceutical & biotechnology environment monitoring market share during the forecast period. On the back of increasing development and adoption of advanced biotechnology in developing countries, including India, China, and Japan, the market in the Asia Pacific region is projected to experience noteworthy growth over the forecast period. Due to economic growth and government initiatives aimed at energy conservation, the Asia Pacific region is expected to have one of the fastest-growing markets during the anticipated timeframe. This will result in a huge demand for micro-biological solutions across numerous industries, including pharmaceuticals and biotechnology. Additionally, growing investment in biotech startups is anticipated to further accelerate market expansion. Around 2,500 biotech enterprises were founded in India, according to studies. In 2019, the Indian biotechnology market was worth USD 63 billion.

European Market Statistics

Over the course of the estimate, Europe is poised to have the second-largest market with a 28% share in this sector. Countries such as the United Kingdom, Germany, Italy, and France have strong demand for environmental monitoring services such as environmental intelligence platform, and others. With the greatest market value of about USD 83,725 million, Germany emerged as the leader, and it is projected to drive the elevate the market’s growth in the region.

Research Nester
Pharmaceutical & Biotechnology Environment Monitoring Market Share
Get more information on this report: Request Free Sample PDF

Companies Dominating the Pharmaceutical & Biotechnology Environment Monitoring Landscape

    • Thermo Fisher Scientific Company
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Springer Nature Limited
    • Applied Microarrays Inc.
    • C D Genomics
    • RELX Group
    • MilliporeSigma
    • QIAGEN
    • Agilent Technologies, Inc.
    • Danaher Corporation
    • Eppendorf SE

In the News

  • Danaher Corporation, the leading global science and medical technology innovator, announced the completion of its acquisition of Aldevron.
  •  CD Genomic slaunched the low-coverage sequencing which can effectively identify novel variants in the genomic databases.

Author Credits:  Radhika Pawar


  • Report ID: 3931
  • Published Date: Jul 26, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of pharmaceutical & biotechnology environment monitoring is assessed at USD 1.1 Billion.

The pharmaceutical & biotechnology environment monitoring market size was valued at USD 1.04 Billion in 2023 and is set to reach USD 2.36 Billion by the end of 2036, registering around 6.5% CAGR during the forecast period i.e., between 2024-2036. The major factors driving the growth of the Pharmaceutical & Biotechnology Environment Monitoring market due to increased safety-related awareness among researchers in the pharmaceutical sector.

Asia Pacific industry is expected to have a 35% of the revenue share by 2036, driven by increasing development and adoption of advanced biotechnology in developing countries.

Thermo Fisher Scientific Company, Springer Nature Limited, Applied Microarrays Inc., C D Genomics, RELX Group, MilliporeSigma, QIAGEN, Agilent Technologies, Inc., Danaher Corporation, Eppendorf SE
Pharmaceutical & Biotechnology Environment Monitoring Market Report Scope
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample